Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic progress on Johnson Matthey IP acq

25 May 2023 07:19

RNS Number : 6378A
Gelion PLC
25 May 2023
 

 

25 May 2023

Gelion plc

("Gelion" or the "Company")

 

Strategic progress update on the Johnson Matthey IP acquisition

for the LiS/LiSiS technologies

 

IP acquisition positions Gelion as a significant player in the lithium-sulfur market,

providing a strong foundation for becoming a global leader in this sector

 

Gelion (AIM: GELN), the Anglo-Australian battery innovator, is pleased to provide an update on the strategic evaluation of the Lithium Sulfur ("LiS") and Silicon Anode ("Si") patent portfolios (the "IP") acquired from Johnson Matthey in March 2023.

 

Through the combination of the newly acquired LiS IP and Gelion's own IP, Gelion has the potential to significantly advance its efforts to revolutionise the energy storage industry by developing sustainable, high-performance LiS batteries with superior energy density (e.g. potential to double EV ranges), high safety and great cost-effectiveness, providing a compelling alternative to current lithium-based battery technologies.

 

Key highlights post-acquisition

 

· Gelion has evaluated the 450 patents across 82 patent families acquired and concluded it is in the Group's best interest to retain the majority of the IP portfolios, strengthening Gelion's future development in the LiS battery market and potentially offering additional commercialisation opportunities, in the areas of lithium battery recycling and salt-based electrode technologies.

· Signed agreement to sell the subset of patents relating to Silicon Anode IP (73 patents across 17 patent families), which are non-core to the Company's particular activities, to Sicona Technologies Pty Ltd ("Sicona"), a silicon anode technology developer in Australia for US$1.5 million (£1.20 million). Gelion will retain the exclusive license (royalty-free) to the Silicon Anode IP, when used in combination with lithium silicon sulfur (LiSiS) or other LiS battery chemistries. 

· Acquisition is assisting in the acceleration of internal R&D and is expected to significantly enhance the Company's future partnership prospects.

 

Commenting on the update, John Wood, CEO said: "It is promising to see that the acquisition of this highly valuable IP portfolio from Johnson Matthey is already bearing fruit in just a few months, providing us with the opportunity to accelerate the development and consequently commercialisation of our own Sulfur cathode platform technology at a faster rate. It is an exciting step forward within the Lithium-based energy storage industry and provides a foundation for Gelion to become a global leader within the sector."

 

Background on the IP portfolio

 

The IP portfolio acquired includes over 450 patents across 82 patent families and includes development programs, technology transfer packages, market and portfolio analyses, manufacturing design and cost models for sulfur-based energy storage technologies.

 

The overall portfolio also includes IP relating to applications of solid-state electrolytes, liquid electrolytes, next-generation cathode materials, processing and manufacture of lithium metal anodes, protective lithium anode coatings, battery management systems, and battery recycling. Gelion is assessing how to best utilise these IP elements to progress its strategic and commercial goals, develop strong relationships and form important partnerships that will assist in the rapid development and commercialisation of our lithium-sulfur battery technology.

 

The IP portfolio is extensive and covers many key areas that, individually and as a group, not only help to provide strong protection against relevant manufacture by competitors in key markets in Asia, North America and Europe, but also provide protection against commercialisation activities in these markets, placing Gelion in a strong competitive IP position with respect to other lithium-sulfur developers.

 

Gelion's unique approach is focused on the development of advanced Sulfur cathode platform solutions that can be paired with a variety of Lithium anode technologies (i.e. silicon, graphite, lithium metal). As these latest generations of Lithium anode technologies become more developed, tested and commercially available, Gelion's technology will be well placed to provide exciting Sulfur cathode pairing solutions.

 

This approach maximises Gelion's capability to provide the dovetailed solutions required to partner with eventually the most dominating next generations of lithium anode technologies.

 

The agreement to sell the subset of patents to Sicona is expected to be completed (with no condition's precedent) and funds transferred by June 2023.

 

 

CONTACTS

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

 

Alma PR (Financial PR Adviser)

Justine James

Hannah Campbell

Will Ellis Hancock

 

+44 20 3405 0205

gelion@almapr.co.uk

 

About Gelion plc

 

Gelion ("gel: ion") is a global renewable-energy storage innovator who supports the transition to a sustainable economy while delivering value for its customers and investors by designing and manufacturing the outstanding zinc-bromide batteries for stationary energy storage and additives for mobile battery applications.

 

Performance Additives - Tomorrow's transport systems will rely on mobile renewable energy. Gelion is developing performance additives and cathode solution based on nanotechnology with the aim of improving the safety, longevity and energy density of lithium-based batteries for mobile applications. Gelion's IP will help power the EV and e-aviation markets.

 

Stationary storage - Gelion Zinc Bromide battery: the sustainable energy storage solution.

Gelion has developed patented technology for a breakthrough zinc-bromide battery to support the transition to a carbon neutral economy by 2050. The technology is being developed with the goal of establishing Gelion Zinc Bromide as a logical participant in the ecosystem of suppliers, manufacturers and customers surrounding lead acid technology. 

 

Gelion's zinc-bromide gel battery uses non-flow technology, which is scalable, can deliver 100% depth of discharge and has potential for higher temperature tolerance and much faster discharge rates, while utilizing all nameplate capacity, representing significant advantages over lead-acid battery technology.

 

Gelion was spun-out from the University of Sydney in 2015 by Professor Thomas Maschmeyer, Fellow of the Australian Academy of Science and recipient of the Australian Prime Minister's Prize for Innovation 2020, that country's highest honour for scientific entrepreneurship.

 

The Company's ESG credentials are strongly aligned to six of the UN's 17 Sustainable Development Goals.

 

Gelion's shares are listed on the AIM market of the London Stock Exchange and it received the Green Economy Mark at IPO in November 2021, recognising its commitment to energy transition.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFIFLREDIEFIV
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.